Enzalutamide plus androgen-deprivation therapy in hormone-sensitive prostate cancer: new perspectives from a current Phase III clinical trial

Future Oncology, Ahead of Print.

Source: Future Oncology - June 23, 2020 Category: Cancer & Oncology Authors: Valentina Norz Laura Lawaczeck Jens Bedke Steffen Rausch Arnulf Stenzl Source Type: research